TABLE III.
PACCI discriminant properties: trend in mean values (95% CIs) of C-ACT and PACQLQ across PACCI categories by using ANOVA
| Mean value of validated measure (95% CI) |
PACCI categories | P value | |||
|---|---|---|---|---|---|
| Controlled (n = 125) | Partly controlled (n = 80) | Uncontrolled (n = 81) | Poorly controlled (n = 31) | ||
| ACT/C-ACT score | |||||
| English* (n = 265) | 22.9 (22.2–23.5) | 18.4 (17.5–19.3) | 15.6 (14.6–16.5) | 13.1 (11.8–14.5) | <.0001 |
| <5 y (n = 75) | 22.7 (21.5–24) | 19 (17.8–20.3) | 15.7 (14.1–17.3) | 13.4 (8.8–18) | <.0001 |
| 5–11 y (n = 119) | 23.2 (22.4–24) | 19 (17.8–20.3) | 15.6 (14.3–16.8) | 14.7 (13–16.3) | <.0001 |
| ≥12 y (n = 71) | 22.6 (21.6–23.7) | 17.6 (15.9–19.2) | 15.3 (13.6–17.1) | 12.3 (9.9–14.6) | <.0001 |
| African American (n = 134) | 22.1 (21.1–23.1) | 17.8 (16.6–19) | 14.9 (13.7–16) | 13 (10.9–15.1) | <.0001 |
| White (n = 99) | 23.5 (22.4–24.5) | 20.1 (18.5–21.7) | 16.7 (15.1–18.4) | 13.6 (11.8–15.3) | <.0001 |
| Spanish (n = 52) | 23.3 (22.4–24.3) | 19.9 (18.5–21.4) | 15.4 (13.1–17.7) | 20.3 (18.9–21.7) | <.0001 |
| PACQLQ score | |||||
| All patients* (n = 265) | 6.4 (6.2–6.5) | 5.2 (4.9–5.5) | 4.8 (4.5–5.1) | 4.6 (4.2–5.1) | <.0001 |
| <5 y (n = 75) | 6.2 (5.9–6.5) | 5.1 (4.6–5.5) | 4.4 (4–4.9) | 5.4 (4.5–6.2) | .0001 |
| 5–11 y (n = 119) | 6.2 (6–6.4) | 5.4 (4.9–5.8) | 4.6 (4.1–5) | 4.7 (4.3–5.1) | <.0001 |
| ≥12 y (n = 71) | 6.6 (6.4–6.9) | 5.2 (4.6–5.8) | 5.1 (4.7–5.6) | 4.5 (3.4–5.7) | <.0001 |
| African American (n = 134) | 6.2 (5.9–6.5) | 5 (4.6–5.4) | 4.5 (4.2–4.9) | 4.5 (3.8–5.2) | <.0001 |
| White (n = 99) | 6.6 (6.4–6.7) | 5.6 (5.3–6) | 5.1 (4.6–5.5) | 4.8 (4.4–5.2) | <.0001 |
| Spanish (n = 52) | 5.9 (5.5–6.4) | 5.5 (4.5–6.4) | 3.4 (2.6–4.1) | 6.3 (5.6–7) | .0001 |
| FEV1 (% predicted) | |||||
| Overall† (n = 118) | 0.90 (0.85–0.94) | 0.88 (0.81–0.96) | 0.88 (0.79–0.96) | 0.84 (0.71–0.96) | .84 |
| English* (n = 79) | 0.88 (0.82–0.94) | 0.84 (0.74–0.93) | 0.86 (0.77–0.96) | 0.79 (0.69–0.9) | .72 |
| 5–11 y (n = 50) | 0.84 (0.78–0.9) | 0.82 (0.63–1) | 0.82 (0.73–0.91) | 0.82 (0.71–0.93) | .98 |
| ≥12 y (n = 29) | 0.97 (0.86–1.08) | 0.85 (0.75–0.95) | 0.96 (0.73–1.19) | 0.62‡ | .31 |
| African American (n = 38) | 0.83 (0.77–0.89) | 0.75 (0.62–0.88) | 0.76 (0.70–0.82) | 0.81 (0.65–0.97) | .55 |
| White (n = 33) | 0.94 (0.84–1.04) | 0.97 (0.88–1.06) | 1.08 (0.92–1.24) | 0.78 (0.64–0.93) | .14 |
| Spanish (n = 39) | 0.92 (0.85–0.99) | 0.97 (0.88–1.06) | 0.92 (0.77–1.07) | 0.98‡ | .79 |
| FEV1/FVC ratio | |||||
| Overall† (n = 118) | 0.90 (0.87–0.93) | 0.88 (0.83–0.92) | 0.86 (0.82–0.90) | 0.85 (0.74–0.96) | .33 |
| English* (n = 79) | 0.85 (0.82–0.88) | 0.83 (0.79–0.88) | 0.85 (0.81–0.89) | 0.82 (0.73–0.91) | .86 |
| 5–11 y (n = 50) | 0.85 (0.81–0.89) | 0.84 (0.75–0.92) | 0.84 (0.79–0.88) | 0.86 (0.79–0.92) | .96 |
| ≥12 y (n = 29) | 0.84 (0.79–0.89) | 0.83 (0.78–0.88) | 0.88 (0.81–0.95) | 0.58‡ | .04 |
| African American (n = 38) | 0.86 (0.81–0.9) | 0.8 (0.73–0.87) | 0.84 (0.78–0.89) | 0.79 (0.62–0.96) | .58 |
| White (n = 33) | 0.85 (0.81–0.89) | 0.85 (0.81–0.9) | 0.87 (0.8–0.94) | 0.84 (0.75–0.93) | .94 |
| Spanish (n = 39) | 1.00 (0.96–1.04) | 0.97 (0.90–1.04) | 0.89 (0.81–0.98) | 0.96‡ | .12 |
*
Refers to all patients who completed the English version of the PACCI.
†
Includes both English- and Spanish-speaking patients who performed spirometry.
‡
No CI is presented because there was only 1 patient in this category.